SCHEMBL30793338

SCHEMBL30793338

CNC(=O)c1nn2c(c1F)CN(C(=O)OC(C)(C)C)CCC2

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.37
▸ S1PR2 O95136 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ SCN9A Q15858 2/20 0.35
▸ NR1H2 P55055 2/20 0.34
▸ GPR119 Q8TDV5 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYBB P04839 1/20 0.33
▸ NOX5 Q96PH1 1/20 0.33
▸ NOX4 Q9NPH5 1/20 0.33
▸ NOX1 Q9Y5S8 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30793120 0.88 GPR119 (0.37) MAPTMEN1KMT2ASCN9ANR1H2
SCHEMBL25337124 0.87 KMT2A (0.36) MAPTMEN1KMT2ANR1H2HPGD
SCHEMBL30793341 0.87 MEN1 (0.38) MAPTMEN1KMT2ANR1H2GPR119
SCHEMBL30793390 0.85 NR1H2 (0.36) MAPTMEN1KMT2ASCN9ANR1H2
SCHEMBL24535292 0.84 GPR119 (0.39) MAPTMEN1KMT2ANR1H2GPR119
SCHEMBL31323684 0.82 ADORA1 (0.42) MAPTMEN1KMT2AGPR119HPGD
SCHEMBL30793319 0.79 MEN1 (0.37) MAPTMEN1KMT2ASCN9ANR1H2
SCHEMBL30793811 0.77 MEN1 (0.37) MAPTMEN1KMT2ANR1H2HPGD
SCHEMBL30793753 0.77 MEN1 (0.37) MAPTMEN1KMT2ANR1H2HPGD
SCHEMBL25338426 0.77 NR1H2 (0.43) MAPTMEN1KMT2ANR1H2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540254-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244604-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-12-21 — — WO disclosed
Send feedback